AACR: At-home HPV testing boosts cervical cancer screening participation

  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 45 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 38%
  • Publisher: 51%

Medicine Research News News

Medicine Research,Health Research News,Health Research

Mailed at-home self-sampling for human papillomavirus (HPV) testing increases cervical cancer screening participation in underscreened populations by almost threefold, according to a study presented at the annual meeting of the American Association for Cancer Research, held from April 5 to 10 in San Diego.

AACR: At-home HPV testing boosts cervical cancer screening participation retrieved 13 April 2024 from https://medicalxpress.com/news/2024-04-aacr-home-hpv-boosts-cervical.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 101. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinomaFor patients with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma, cadonilimab plus chemotherapy is associated with improved overall survival and progression-free survival, according to a study presented at the annual meeting of the American Association for Cancer Research, held from April 5 to 10 in San Diego.
Source: medical_xpress - 🏆 101. / 51 Read more »

Investigational personalized vaccine provides clinical benefit for some patients with resected head and neck cancersTG4050, a personalized neoantigen vaccine, induced tumor-specific immune responses and led to low rates of disease relapse in patients with surgically resected HPV-negative head and neck squamous cell cancer (HNSCC), according to results reported at the American Association for Cancer Research (AACR) Annual Meeting 2024, held April 5–10.
Source: medical_xpress - 🏆 101. / 51 Read more »

Oncologist suggests three ways to prevent head and neck cancerThroat cancer is one of the fastest-growing cancers, and it is often linked to HPV. Oropharyngeal cancer, or throat cancer, is a type of head and neck cancer that can be divided into two subgroups: HPV-associated cancers and non-HPV-associated cancers. And depending on the type of subgroup, they are treated differently.
Source: medical_xpress - 🏆 101. / 51 Read more »

Researchers identify new genetic risk factors for persistent HPV infectionsHuman papillomavirus (HPV) is the second most common cancer-causing virus, accounting for 690,000 cervical and other cancers each year worldwide.
Source: medical_xpress - 🏆 101. / 51 Read more »

New genetic variants could raise a woman's risk of cervical cancer from HPV infectionsHuman papillomavirus (HPV) is the second most common cancer-causing virus, accounting for 690,000 cervical and other cancers each year worldwide.
Source: NewsMedical - 🏆 19. / 71 Read more »